DDX41 germline variants causing donor cell leukemia indicate a need for further genetic workup in the context of hematopoietic stem cell transplantation

• Benjamin Rolles,
• Robert Meyer,
• Matthias Begemann,
• Miriam Elbracht,
• Edgar Jost,
• Matthias Stelljes,
• Ingo Kurth,
• Tim H. Brümmendorf,
• Gerda Silling

Affiliations

Benjamin Rolles

Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University

Robert Meyer

Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD)

Matthias Begemann

Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD)

Miriam Elbracht

Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD)

Edgar Jost

Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University

Matthias Stelljes

Department of Medicine A, Hematology and Oncology, University of Muenster

Ingo Kurth

Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD)

Tim H. Brümmendorf

Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University

Gerda Silling

Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University